This post was originally published on this site
The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
Headline
FDA approves generic version of Novo Nordisk’s GLP-1 diabetes drug Victoza
Back To Top